Loading...

Media is loading
 

Date of Award

Spring 2025

Degree Name

Master of Medical Science (Physician Assistant)

Department

Physician Assistant; College of Health Sciences

First Advisor

Sophie Farley

Abstract

Parkinson's disease is a complicated neurodegenerative condition with distinct motor subtypes that require tailored management approaches. While levodopa remains the cornerstone of therapy, response rates and disease progression vary significantly among patients, particularly between tremor-dominant Parkinson's disease (TD-PD) and postural instability/gait difficulty (PIGD) subtypes. Clinicians often struggle to distinguish these motor subtypes and apply evidence-based, subtype-specific management strategies. This reviews the latest research on the pathophysiology, clinical presentation, and treatment of PD motor subtypes, providing clinicians with practical guidance on optimizing pharmacologic and non-pharmacologic interventions to individualize treatment plans. Improved recognition and management of PD motor subtypes will ultimately lead to better patient outcomes, reducing fall risk, medication-related complications, and functional decline.

Share

COinS
 

Parkinson’s Disease Motor Subtypes: Classification, Pathophysiology, Manifestations, and Tailored Treatment Strategies

Parkinson's disease is a complicated neurodegenerative condition with distinct motor subtypes that require tailored management approaches. While levodopa remains the cornerstone of therapy, response rates and disease progression vary significantly among patients, particularly between tremor-dominant Parkinson's disease (TD-PD) and postural instability/gait difficulty (PIGD) subtypes. Clinicians often struggle to distinguish these motor subtypes and apply evidence-based, subtype-specific management strategies. This reviews the latest research on the pathophysiology, clinical presentation, and treatment of PD motor subtypes, providing clinicians with practical guidance on optimizing pharmacologic and non-pharmacologic interventions to individualize treatment plans. Improved recognition and management of PD motor subtypes will ultimately lead to better patient outcomes, reducing fall risk, medication-related complications, and functional decline.